CAS 1609

Known as: CAS-1609

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

Review

1999

Review

1999

Heterocyclic NO prodrugs.

K. Schönafinger
Farmaco
1999

Corpus ID: 39902232

An overview of the different heterocyclic NO-releasing compounds is given. Mesoionic heterocycles like sydnone imines are one… Expand

1997

1997

Lysophosphatidylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature.

R. Scalia, T. Murohara, B. Campbell, A. Kaji, A. Lefer
The American journal of physiology
1997

Corpus ID: 25177494

Synthetic exogenous lysophosphatidylcholine (LPC) was used to induce leukocyte-endothelial cell interaction, utilizing intravital… Expand

Highly Cited

1995

Highly Cited

1995

Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury.

J. P. Guo, M. Panday, P. Consigny, A. Lefer
The American journal of physiology
1995

Corpus ID: 24132557

We studied the effects of a novel organic nitric oxide (NO) donor, 4-hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609… Expand

Highly Cited

1995

Highly Cited

1995

Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function.

R. Pabla, A. Buda, D. Flynn, D. Salzberg, D. Lefer
The American journal of physiology
1995

Corpus ID: 9210620

In the present study a novel nitric oxide (NO) donor, CAS-1609, was utilized as a means of coronary NO replenishment in a canine… Expand